Bill Status of SB 2100   94th General Assembly

Short Description:  REGENERATIVE MEDICINE INSTITUT

Senate Sponsors
Sen. Jeffrey M. Schoenberg-Carol Ronen-Don Harmon-Mattie Hunter-Martin A. Sandoval, Kwame Raoul, Iris Y. Martinez and John J. Cullerton

Last Action  View All Actions

DateChamber Action
  1/9/2007SenateSession Sine Die

Statutes Amended In Order of Appearance
New Act
5 ILCS 120/2from Ch. 102, par. 42
10 ILCS 5/Art. 28A heading new
10 ILCS 5/28A-5 new
10 ILCS 5/28A-10 new
10 ILCS 5/28A-15 new
10 ILCS 5/28A-20 new
10 ILCS 5/28A-25 new
10 ILCS 5/28A-30 new
10 ILCS 5/28A-35 new
10 ILCS 5/28A-40 new
30 ILCS 105/5.640 new
30 ILCS 105/6z-100 new
30 ILCS 105/6z-105 new
30 ILCS 330/2from Ch. 127, par. 652
30 ILCS 330/6.5 new
30 ILCS 330/12from Ch. 127, par. 662
30 ILCS 330/19from Ch. 127, par. 669

Synopsis As Introduced
Creates the Illinois Regenerative Medicine Institute Act. Requires that the 2006 general election ballot include the proposition that the State issue $1,000,000,000 in general obligation bonds in support of stem cell research. Creates the Illinois Regenerative Medicine Institute Creation Act to provide for the governance and operation of the institute, which awards grants and loans for the research. Creates the Cosmetic Medical Procedure Utilization Tax Act to impose a tax upon the privilege of using cosmetic medical procedures at the rate of 6% of gross receipts. Amends the Open Meetings Act to permit closed meetings of the Institute's Oversight Committee and advisory panels on certain confidential topics. Amends the Election Code to provide for placement on the ballot of debt issuance referenda under the Revenue Article of the Illinois Constitution. Amends the State Finance Act to provide various funds for the institute operations, the tax proceeds, and the bond proceeds and retirement. Amends the General Obligation Bond Act to provide for the issuance and use of $1,000,000,000 in bonds. Effective January 1, 2006, except for those portions (institute creation, tax imposition, and bond issuance) conditioned upon voter approval.

 State Debt Impact Note (Government Forecasting & Accountability)
 SB2100 would raise general obligation bond authorization by $1.0 billion for stem cell research, selling approximately $100 million a year for ten years: Potential General Obligation debt $1.8 billion. Debt service 1st year $10.4 million. Debt service 10th year (highest) $91.8 million. Debt service 20th year $66.2 million. Debt service 34th year (final year) $4.2 million.

 Fiscal Note (Government Forecasting & Accountability)
 SB 2100 would increase State revenues by an undetermined amount by taxing cosmetic surgery procedures.

Actions 
DateChamber Action
  2/25/2005SenateFiled with Secretary by Sen. Jeffrey M. Schoenberg
  2/25/2005SenateFirst Reading
  2/25/2005SenateReferred to Rules
  3/2/2005SenateAssigned to Health & Human Services
  3/3/2005SenateAdded as Chief Co-Sponsor Sen. Carol Ronen
  3/7/2005SenateAdded as Chief Co-Sponsor Sen. Don Harmon
  3/10/2005SenatePostponed - Health & Human Services
  3/10/2005SenateAdded as Chief Co-Sponsor Sen. Mattie Hunter
  3/10/2005SenateAdded as Chief Co-Sponsor Sen. Martin A. Sandoval
  3/10/2005SenateAdded as Co-Sponsor Sen. Kwame Raoul
  3/10/2005SenateAdded as Co-Sponsor Sen. Iris Y. Martinez
  3/16/2005SenateAdded as Co-Sponsor Sen. John J. Cullerton
  3/17/2005SenateDo Pass Health & Human Services; 007-004-000
  3/17/2005SenatePlaced on Calendar Order of 2nd Reading April 6, 2005
  4/6/2005SenateFiscal Note Requested by Sen. Dale A. Righter
  4/6/2005SenateState Debt Impact Note Requested by Sen. Dale A. Righter
  4/7/2005SenateState Debt Impact Note Filed from the Commission on Government Forecasting and Accountability.
  4/7/2005SenateFiscal Note Filed from the Commission on Government Forecasting and Accountability.
  4/11/2005SenateSecond Reading
  4/11/2005SenatePlaced on Calendar Order of 3rd Reading April 12, 2005
  5/10/2005SenateMotion Filed Sen. Louis S. Viverito; , Cullerton, Hendon, Petka and Roskam, Motion to Re-refer, pursuant to Senate Rule 3-7. Re-referred to the Senate Rules Committee.
  5/10/2005SenateMotion Prevailed
  5/10/2005SenateRe-referred to Rules
  1/9/2007SenateSession Sine Die

Back To Top